MD-2 is a new predictive biomarker in dilated cardiomyopathy and exerts direct effects in isolated cardiomyocytes.
Riad A, Gross S, Witte J, Feldtmann R, Wagner KB, Reinke Y, Weitmann K, Empen K, Beug D, Westermann D, Lindner D, Klingel K, Dörr M, Hoffmann W, Felix SB.
Riad A, et al. Among authors: feldtmann r.
Int J Cardiol. 2018 Nov 1;270:278-286. doi: 10.1016/j.ijcard.2018.06.025. Epub 2018 Jun 13.
Int J Cardiol. 2018.
PMID: 30082120